{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-25-009183","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.418578+00:00","generated_at":"2026-05-18T03:39:33.362674+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bausch + Lomb CEO amends employment agreement; PSUs now tied to share price and EBITDA goals through 2029","bullets":["CEO Brenton Saunders gave up 'good reason' severance right tied to spin-off timing from Bausch Health.","Amended PSUs vest Feb 23, 2029; payout range 120%-330% of target based on share-price hurdles ($26.57-$39.06).","Cumulative Adjusted EBITDA performance modifier for FY2025-2028 can adjust payout by -40% to +40%.","PSU payout also subject to Saunders' continued employment through the performance period.","Full text of amendments will be filed in Q3 2025 10-Q."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-25-009183","json":"https://secwatch.observer/filing/0000950103-25-009183.json","markdown":"https://secwatch.observer/filing/0000950103-25-009183.md","text":"https://secwatch.observer/filing/0000950103-25-009183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000095010325009183/0000950103-25-009183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000095010325009183/dp231940_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:39:33.362674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}